Clinical Trials Browser

Not yet recruiting × Lung Neoplasms × Carboplatin × Clear all

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07307443 2025-12-29

A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.

Phase 2 Not yet recruiting

28 enrolled

Thoracic

Lung Neoplasms

NCT07279935 2025-12-12

REVIVE

Phase 4 Not yet recruiting

100 enrolled

Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT06970782 2025-05-21

KYLIN-3

Phase 3 Not yet recruiting

278 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06688656 2024-11-14

Peri-E

Phase 2 Not yet recruiting

30 enrolled

Thoracic

Lung Neoplasms

NCT05484583 2022-08-05

Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases

Phase 2 Not yet recruiting

58 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Clinical Trials

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.

REVIVE

KYLIN-3

Peri-E

Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases